These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
316 related articles for article (PubMed ID: 27671543)
1. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia. Jain S; Jain S; Kapoor G; Virmani A; Bajpai R Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543 [TBL] [Abstract][Full Text] [Related]
2. Bone mineral density, body composition, and height in long-term survivors of acute lymphoblastic leukemia in childhood. van der Sluis IM; van den Heuvel-Eibrink MM; Hählen K; Krenning EP; de Muinck Keizer-Schrama SM Med Pediatr Oncol; 2000 Oct; 35(4):415-20. PubMed ID: 11025472 [TBL] [Abstract][Full Text] [Related]
3. Male sex and low physical activity are associated with reduced spine bone mineral density in survivors of childhood acute lymphoblastic leukemia. Tillmann V; Darlington AS; Eiser C; Bishop NJ; Davies HA J Bone Miner Res; 2002 Jun; 17(6):1073-80. PubMed ID: 12054163 [TBL] [Abstract][Full Text] [Related]
4. Severity of reduced bone mineral density and risk of fractures in long-term survivors of childhood leukemia and lymphoma undergoing guideline-recommended surveillance for bone health. Bloomhardt HM; Sint K; Ross WL; Rotatori J; Ness K; Robinson C; Carpenter TO; Chow EJ; Kadan-Lottick NS Cancer; 2020 Jan; 126(1):202-210. PubMed ID: 31536650 [TBL] [Abstract][Full Text] [Related]
6. Relationships of Bone Mineral Density to Whole Body Mass, Fat Mass and Fat-free Mass in Long-term Survivors of Acute Lymphoblastic Leukemia in Childhood. Athale UH; Marriott CJC; Cranston A; McDonald P; Webber CE; Farncombe TH; Barr RD J Pediatr Hematol Oncol; 2021 Jan; 43(1):12-17. PubMed ID: 32675554 [TBL] [Abstract][Full Text] [Related]
7. [Accretion of bone mass in patients treated for childhood acute lymphoblastic leukemia]. Muszyńska-Rosłan K; Konstantynowicz J; Krawczuk-Rybak M Pol Merkur Lekarski; 2007 Oct; 23(136):271-5. PubMed ID: 18293849 [TBL] [Abstract][Full Text] [Related]
8. Genetic susceptibility and late bone outcomes in childhood acute lymphoblastic leukemia survivors. Geneviève N; Mojgan Y; Nahid Y; Vincenzo F; Simon G; Daniel S; Maja K; Nathalie A; Despoina M J Bone Miner Res; 2024 Mar; 39(2):130-138. PubMed ID: 38477791 [TBL] [Abstract][Full Text] [Related]
9. Bone mass after treatment for acute lymphoblastic leukemia in childhood. Nysom K; Holm K; Michaelsen KF; Hertz H; Müller J; Mølgaard C J Clin Oncol; 1998 Dec; 16(12):3752-60. PubMed ID: 9850018 [TBL] [Abstract][Full Text] [Related]
10. Bone mineral density in survivors of childhood acute lymphoblastic leukemia. Athanassiadou F; Tragiannidis A; Rousso I; Katsos G; Sidi V; Papageorgiou T; Papastergiou C; Tsituridis I; Koliouskas D Turk J Pediatr; 2006; 48(2):101-4. PubMed ID: 16848106 [TBL] [Abstract][Full Text] [Related]
11. Calcium and cholecalciferol supplementation provides no added benefit to nutritional counseling to improve bone mineral density in survivors of childhood acute lymphoblastic leukemia (ALL). Kaste SC; Qi A; Smith K; Surprise H; Lovorn E; Boyett J; Ferry RJ; Relling MV; Shurtleff SA; Pui CH; Carbone L; Hudson MM; Ness KK Pediatr Blood Cancer; 2014 May; 61(5):885-93. PubMed ID: 24395288 [TBL] [Abstract][Full Text] [Related]
12. Assessment of bone mineral density and risk factors in children completing treatment for acute lymphoblastic leukemia. Gunes AM; Can E; Saglam H; Ilçöl YO; Baytan B J Pediatr Hematol Oncol; 2010 Apr; 32(3):e102-7. PubMed ID: 20216235 [TBL] [Abstract][Full Text] [Related]
13. Bone mineral density and serum bone turnover markers in survivors of childhood acute lymphoblastic leukemia: comparison of megadose methylprednisolone and conventional-dose prednisolone treatments. Alikasifoglu A; Yetgin S; Cetin M; Tuncer M; Gumruk F; Gurgey A; Yordam N Am J Hematol; 2005 Oct; 80(2):113-8. PubMed ID: 16184587 [TBL] [Abstract][Full Text] [Related]
14. Improvement in bone mineral density and body composition in survivors of childhood acute lymphoblastic leukemia: a 1-year prospective study. Marinovic D; Dorgeret S; Lescoeur B; Alberti C; Noel M; Czernichow P; Sebag G; Vilmer E; Léger J Pediatrics; 2005 Jul; 116(1):e102-8. PubMed ID: 15995009 [TBL] [Abstract][Full Text] [Related]
15. Little evidence of low bone mass in acute lymphoblastic leukemia survivors. Muszynska-Roslan K; Panasiuk A; Latoch E; Krawczuk-Rybak M; Konstantynowicz J J Clin Densitom; 2012; 15(1):108-15. PubMed ID: 21880524 [TBL] [Abstract][Full Text] [Related]
16. Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study. Mäkitie O; Heikkinen R; Toiviainen-Salo S; Henriksson M; Puukko-Viertomies LR; Jahnukainen K Eur J Endocrinol; 2013 Feb; 168(2):281-8. PubMed ID: 23197573 [TBL] [Abstract][Full Text] [Related]
17. Bone mineral density and markers of bone turnover in young adult survivors of childhood lymphoblastic leukaemia. Hoorweg-Nijman JJ; Kardos G; Roos JC; van Dijk HJ; Netelenbos C; Popp-Snijders C; de Ridder CM; Delemarre-van de Waal HA Clin Endocrinol (Oxf); 1999 Feb; 50(2):237-44. PubMed ID: 10396368 [TBL] [Abstract][Full Text] [Related]
18. No difference between prednisolone and dexamethasone treatment in bone mineral density and growth in long term survivors of childhood acute lymphoblastic leukemia. van Beek RD; de Muinck Keizer-Schrama SM; Hakvoort-Cammel FG; van der Sluis IM; Krenning EP; Pieters R; van den Heuvel-Eibrink MM Pediatr Blood Cancer; 2006 Jan; 46(1):88-93. PubMed ID: 15926166 [TBL] [Abstract][Full Text] [Related]
19. Adequate calcium intake during long periods improves bone mineral density in healthy children. Data from the Childhood Obesity Project. Closa-Monasterolo R; Zaragoza-Jordana M; Ferré N; Luque V; Grote V; Koletzko B; Verduci E; Vecchi F; Escribano J; Clin Nutr; 2018 Jun; 37(3):890-896. PubMed ID: 28351509 [TBL] [Abstract][Full Text] [Related]
20. Total body bone measurements: a cross-sectional study in children with acute lymphoblastic leukemia during and following completion of therapy. Kelly KM; Thornton JC; Hughes D; Osunkwo I; Weiner M; Wang J; Horlick M Pediatr Blood Cancer; 2009 Jan; 52(1):33-8. PubMed ID: 18816694 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]